26 October 2010
? Introducing a Safer Drug Regime
? Targeting $3 Billion in Revenue by Year Five
? Strategic Positioning
Stirling is positioning itself to achieve annual revenue share of between $3 to $6 billion from HDA delivered drug sales by year five.
(.>_<) =?
time for a new thread, page-22
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)